Welcome

  • Topic highlights
    Globalisation; Regional Innovation, Innovation Management
  • Experienced professionals from around the globe debating developments in innovation and tech transfer

Search this and other Innovation sites

  • Search this Blog using Rollyo (Yahoo)

  • Search using Google
    Google

    WWW
    maxinno.typepad.com

Sites you should visit

Editors

  • Ernst Max Nielsen
    Max has worked 20+ years with TT as owner, manager, director and /or board member in both small and large companies, comprising TT consulting, high-tech startups, international groups – in USA, Russia, UK, Belgium, Hungary and his native Denmark. Max operates as a business angel investor.

About

« Newswire / Press Release: China Holding Nanotechnology to Dominate the Scientific World - Nanotechnology | NewswireToday | Main | Greenhouse gas plastics »

Merck Serono and EPFL announce Research Partnership in Neuroscience, Oncology and Drug Delivery

First Allergan. EPFL does it again!!

Merck Serono and EPFL announce Research Partnership in Neuroscience, Oncology and Drug Delivery: "


Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced today the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson’s; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.

Category: Press
Date: 31 Oct 2007

"

(Via AlphaGalileo Technology Channel.)

November 04, 2007 |